We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.04%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$186M
AUM Growth
+$24.6M
(+15%)
Cap. Flow
+$9.73M
Cap. Flow
% of AUM
5.24%
Top 10 Holdings %
Top 10 Hldgs %
43.12%
Holding
84
New
10
Increased
18
Reduced
10
Closed
11
Top Buys
| 1 |
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
|
+$4.09M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$3.14M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$2.82M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$2.79M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$2.06M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$1.85M |
| 2 |
uniQure
QURE
|
+$1.68M |
| 3 |
Insulet
PODD
|
+$1.64M |
| 4 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
+$1.48M |
| 5 |
ONC
BeOne Medicines Ltd
ONC
|
+$961K |
Sector Composition
| 1 | Healthcare | 82.51% |
| 2 | Financials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $24.9M | 13.42% |
296,000
+33,879
| +13% | +$2.82M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $7.59M | 4.09% |
100,691
+24,691
| +32% | +$1.74M |
|
3
AtriCure
ATRC
$1.75B
| $7.1M | 3.82% |
389,145
+5,000
| +1% | +$99K |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals
AERI
| $6.98M | 3.76% |
116,770
| – | – |
|
5
argenx
ARGX
$54B
| $6.02M | 3.24% |
95,396
+55,396
| +138% | +$1.81M |
|
|
ONC
6
BeOne Medicines Ltd
ONC
$32.3B
| $6M | 3.23% |
61,349
-10,500
| -15% | -$961K |
|
7
BioCryst Pharmaceuticals
BCRX
$2.39B
| $5.86M | 3.16% |
1,193,228
| – | – |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $5.37M | 2.89% |
134,147
+81,647
| +156% | +$3.14M |
|
|
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
| $5.24M | 2.82% |
216,119
| – | – |
|
10
Ascendis Pharma A/S
ASND
$17.6B
| $4.99M | 2.69% |
124,639
+52,413
| +73% | +$1.91M |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $4.91M | 2.65% |
304,000
-156,451
| -34% | -$1.85M |
|
12
DexCom
DXCM
$28.1B
| $4.76M | 2.57% |
332,000
+102,000
| +44% | +$1.33M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $4.74M | 2.55% |
+28,800
| New | +$2.79M |
|
|
VBIV
14
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $4.26M | 2.29% |
+33,267
| New | +$4.09M |
|
15
Neurocrine Biosciences
NBIX
$17.3B
| $4.23M | 2.28% |
54,508
| – | – |
|
|
ALDR
16
DELISTED
Alder Biopharmaceuticals
ALDR
| $3.96M | 2.13% |
346,013
| – | – |
|
|
17
Rigel Pharmaceuticals
RIGL
$762M
| $3.82M | 2.06% |
98,348
+54,000
| +122% | +$2.06M |
|
|
LKFT
18
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $3.71M | 2% |
39,609
+8,000
| +25% | +$757K |
|
|
CBAY
19
DELISTED
Cymabay Therapeutics
CBAY
| $3.32M | 1.79% |
361,164
-73,836
| -17% | -$631K |
|
20
MacroGenics
MGNX
$275M
| $2.93M | 1.58% |
154,200
| – | – |
|
|
VIRX
21
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.89M | 1.56% |
22,371
-1,381
| -6% | -$129K |
|
22
iShares Biotechnology ETF
IBB
$9.24B
| $2.79M | 1.5% |
26,100
| – | – |
|
|
ACHN
23
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.73M | 1.47% |
948,272
+230,000
| +32% | +$836K |
|
|
BEAT
24
DELISTED
BioTelemetry, Inc.
BEAT
| $2.63M | 1.42% |
88,100
+38,100
| +76% | +$1.1M |
|
25
Voyager Therapeutics
VYGR
$193M
| $2.61M | 1.4% |
157,000
+39,741
| +34% | +$681K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML